世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global COPD Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5676
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・COPD治療薬の市場動向
・企業の競争状況、市場シェア
・COPD治療薬の種類別市場規模と予測2016-2027（気管支拡張薬、吸入コルチコステロイド、その他）
・COPD治療薬の用途別市場規模と予測2016-2027（大人用、子供用）
・COPD治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・COPD治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・COPD治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・COPD治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・COPD治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、AstraZeneca、Theravance Biopharma、Mylan）
・結論

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world.

Market Analysis and Insights: Global COPD Therapeutics Market
The global COPD Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COPD Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COPD Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COPD Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COPD Therapeutics market.

Global COPD Therapeutics Scope and Market Size
COPD Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COPD Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bronchodilators
Inhaled Corticosteroids
Other

Segment by Application
Adult
Child

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchodilators
1.2.3 Inhaled Corticosteroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global COPD Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COPD Therapeutics Market Perspective (2016-2027)
2.2 COPD Therapeutics Growth Trends by Regions
2.2.1 COPD Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COPD Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 COPD Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 COPD Therapeutics Industry Dynamic
2.3.1 COPD Therapeutics Market Trends
2.3.2 COPD Therapeutics Market Drivers
2.3.3 COPD Therapeutics Market Challenges
2.3.4 COPD Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COPD Therapeutics Players by Revenue
3.1.1 Global Top COPD Therapeutics Players by Revenue (2016-2021)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COPD Therapeutics Revenue
3.4 Global COPD Therapeutics Market Concentration Ratio
3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2020
3.5 COPD Therapeutics Key Players Head office and Area Served
3.6 Key Players COPD Therapeutics Product Solution and Service
3.7 Date of Enter into COPD Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Therapeutics Breakdown Data by Type
4.1 Global COPD Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global COPD Therapeutics Forecasted Market Size by Type (2022-2027)

5 COPD Therapeutics Breakdown Data by Application
5.1 Global COPD Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global COPD Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COPD Therapeutics Market Size (2016-2027)
6.2 North America COPD Therapeutics Market Size by Type
6.2.1 North America COPD Therapeutics Market Size by Type (2016-2021)
6.2.2 North America COPD Therapeutics Market Size by Type (2022-2027)
6.2.3 North America COPD Therapeutics Market Size by Type (2016-2027)
6.3 North America COPD Therapeutics Market Size by Application
6.3.1 North America COPD Therapeutics Market Size by Application (2016-2021)
6.3.2 North America COPD Therapeutics Market Size by Application (2022-2027)
6.3.3 North America COPD Therapeutics Market Size by Application (2016-2027)
6.4 North America COPD Therapeutics Market Size by Country
6.4.1 North America COPD Therapeutics Market Size by Country (2016-2021)
6.4.2 North America COPD Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe COPD Therapeutics Market Size (2016-2027)
7.2 Europe COPD Therapeutics Market Size by Type
7.2.1 Europe COPD Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe COPD Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe COPD Therapeutics Market Size by Type (2016-2027)
7.3 Europe COPD Therapeutics Market Size by Application
7.3.1 Europe COPD Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe COPD Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe COPD Therapeutics Market Size by Application (2016-2027)
7.4 Europe COPD Therapeutics Market Size by Country
7.4.1 Europe COPD Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe COPD Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COPD Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific COPD Therapeutics Market Size by Type
8.2.1 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific COPD Therapeutics Market Size by Application
8.3.1 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific COPD Therapeutics Market Size by Region
8.4.1 Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COPD Therapeutics Market Size (2016-2027)
9.2 Latin America COPD Therapeutics Market Size by Type
9.2.1 Latin America COPD Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America COPD Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America COPD Therapeutics Market Size by Type (2016-2027)
9.3 Latin America COPD Therapeutics Market Size by Application
9.3.1 Latin America COPD Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America COPD Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America COPD Therapeutics Market Size by Application (2016-2027)
9.4 Latin America COPD Therapeutics Market Size by Country
9.4.1 Latin America COPD Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America COPD Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COPD Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa COPD Therapeutics Market Size by Type
10.2.1 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa COPD Therapeutics Market Size by Application
10.3.1 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa COPD Therapeutics Market Size by Country
10.4.1 Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Therapeutics Introduction
11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Details
11.3.2 Theravance Biopharma Business Overview
11.3.3 Theravance Biopharma COPD Therapeutics Introduction
11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021)
11.3.5 Theravance Biopharma Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan COPD Therapeutics Introduction
11.4.4 Mylan Revenue in COPD Therapeutics Business (2016-2021)
11.4.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Other
Table 5. Global COPD Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global COPD Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global COPD Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global COPD Therapeutics Market Share by Regions (2016-2021)
Table 9. Global COPD Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global COPD Therapeutics Market Share by Regions (2022-2027)
Table 11. COPD Therapeutics Market Trends
Table 12. COPD Therapeutics Market Drivers
Table 13. COPD Therapeutics Market Challenges
Table 14. COPD Therapeutics Market Restraints
Table 15. Global COPD Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global COPD Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020)
Table 18. Ranking of Global Top COPD Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COPD Therapeutics Product Solution and Service
Table 22. Date of Enter into COPD Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global COPD Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global COPD Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global COPD Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global COPD Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline COPD Therapeutics Product
Table 65. GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca COPD Therapeutics Product
Table 70. AstraZeneca Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Theravance Biopharma Company Details
Table 73. Theravance Biopharma Business Overview
Table 74. Theravance Biopharma COPD Therapeutics Product
Table 75. Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Theravance Biopharma Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan COPD Therapeutics Product
Table 80. Mylan Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Bronchodilators Features
Figure 3. Inhaled Corticosteroids Features
Figure 4. Other Features
Figure 5. Global COPD Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Adult Case Studies
Figure 7. Child Case Studies
Figure 8. COPD Therapeutics Report Years Considered
Figure 9. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global COPD Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global COPD Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global COPD Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global COPD Therapeutics Market Share by Players in 2020
Figure 14. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2020
Figure 16. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global COPD Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America COPD Therapeutics Market Share by Type (2016-2027)
Figure 20. North America COPD Therapeutics Market Share by Application (2016-2027)
Figure 21. North America COPD Therapeutics Market Share by Country (2016-2027)
Figure 22. United States COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe COPD Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe COPD Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe COPD Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific COPD Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific COPD Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific COPD Therapeutics Market Share by Region (2016-2027)
Figure 38. China COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America COPD Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America COPD Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America COPD Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa COPD Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa COPD Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa COPD Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 59. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Medication Market Size, Status and Forecast 2021-2027
QFJ1-5675 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、COPD用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬）、用途別市場規模（病院、診療所、薬局、...

世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年）

Global Asthma/COPD Combination Medication Market Size, Status and Forecast 2021-2027
QFJ1-5601 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、喘息/COPD併用薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブデソニド、LAMA / LABAコンボ、フルチカゾン/サルメテロール）、用途別市場規模（中等度COPD、重度COPD、喘息）、主要...

世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年）

Global Anti-Asthmatics and COPD Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3819 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、抗喘息薬＆COPD薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4015 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、慢性閉塞性肺疾患（COPD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他）、用途別市場規模（病院、診療所、小売薬局、その...

世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5602 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の未分化甲状腺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3802 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のアトピー性皮膚炎治療薬市場規模・現状・予測（2021年-2027年）

Global Atopic Dermatitis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3867 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、アトピー性皮膚炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用剤、全身療法）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の抗菌治療薬市場規模・現状・予測（2021年-2027年）

Global Antimicrobial Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5586 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、抗菌治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（病院、診療所、個人、その他）、用途別市場規模（抗ウイルス剤、抗菌剤、抗真菌剤、駆虫剤）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の脾腫治療薬市場規模・現状・予測（2021年-2027年）

Global Splenomegaly Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-6019 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脾腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、予防接種、その他）、用途別市場規模（正常（非脾腫）、中等度脾腫、重度脾腫）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のロタウイルス感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Rotavirus Infection Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4839 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ロタウイルス感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matt…
世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Asthma/COPD Combination Medication Market The global Asthma/COPD Combination Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market The global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is projected to reach US$ 16110 million by 2027, from US$ 12890 million in 2020, at a CAGR of 2.8% during 2021-2027. With i…
世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年） The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The cla…
世界のアトピー性皮膚炎治療薬市場規模・現状・予測（2021年-2027年） Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions. Market Analysis and…